Post-IPO Equity - Arcellx
Investment Firm
Overview
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Announced Date
Dec 09, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Arcellx raised $100000000 on 2022-12-09 in Post-IPO Equity
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 10, 2022 |  Post-IPO Equity - Arcellx | - | 10.0M | |
| Jun 15, 2022 | Post-IPO Equity - Arcellx | - | 112.0M | |
| Dec 09, 2022 | Post-IPO Equity - Arcellx | 1 | - | 100.0M |
| Nov 15, 2023 | Post-IPO Equity - Arcellx | 1 | - | 200.0M |
Recent Activity
There is no recent news or activity for this profile.